TABLE 4.
R or difference in ΔZTBBMD (18-0) (CI) | |||||||||
---|---|---|---|---|---|---|---|---|---|
ALL | CD | UC | |||||||
VARIABLE | N | R/difference | p | N | R/difference | p | N | R/difference | P |
ZTBBMD(screening) | 48 | −0.304 | 0.04 | 36 | −0.339 | 0.04 | |||
ΔZHt | 48 | 0.48 | 0.001 | 36 | 0.658 | 0.000 | |||
Average ESR | 48 | −0.458 | 0.001 | 36 | −0.397 | 0.02 | 12 | −0.664 | 0.02 |
Average CRP | 48 | −0.387 | 0.007 | 36 | −0.356 | 0.03 | |||
Average HCT | 48 | 0.355 | 0.01 | 36 | 0.324 | 0.05 | |||
Average PLT | 48 | −0.382 | 0.007 | 36 | −0.330 | 0.05 | |||
Average albumin | 48 | 0.42 | 0.001 | 36 | 0.518 | 0.001 | |||
Average Fe | 48 | 0.461 | 0.001 | 12 | 0.709 | 0.01 | |||
Average 25OHD | 47 | −0.292 | 0.05 | ||||||
Wt bearing activity 1 | 46 | 0.306 | 0.04 | ||||||
Hospitalization 2 | 10/26 | −0.53 (−0.95,−0.1) | 0.02 | ||||||
Immunomodulators 2 | 39/47 | −0.49 (−0.91, −0.07) | 0.02 | ||||||
Surgery 2 | 5/48 | −0.6 (−1.08, −0.11) | 0.02 | 4/36 | −0.65(−1.28,−0.03) | 0.04 | |||
Disease activity 2 | IN:16 3 M:23 M/S:9 |
−0.71 (−1.23, −0.2) (moderate/severe vs. inactive) | 0.003 | IN: 9 3 MI:19 M/S:8 |
−0.8 (−1.45,−0.16) (moderate/severe vs. inactive) | 0.006 |
R: correlation coefficient, difference in ΔZTBBMD: ΔZTBBMD in comparison group – ΔZTBBMD in reference group, CD: Crohn disease, BMD: bone mineral density, R: correlation coefficient, ΔZTBBMD: change in total body bone mineral density Z-score, CI: 95% confidence intervals, ZTBBMD: total body bone mineral density Z-score, ΔZHt: change in height Z-score, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, HCT: hematocrit, PLT: platelets, Fe: serum iron, 25OHD: serum twenty five hydroxy vitamin D, Wt: weight
hr/wk,
reference group: no hospitalization, no immunomodulators, no surgery, inactive disease status,
I/M/M/S: Inactive/Mild/Moderate and severe